Index of artpub/2024/pmc_11589615/

Siena, Salvatore
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer : biomarker analyses of DESTINY-CRC01
2024
https://ddd.uab.cat/record/305695